Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Syndax Pharmaceuticals Inc | Director | Common Stock | 65K | $1.19M | $18.27 | Feb 7, 2024 | Direct |
Emergent BioSolutions Inc. | Director | Common Stock | 59.9K | $346K | $5.78 | May 23, 2024 | Direct |
RIGEL PHARMACEUTICALS INC | Director | Common Stock | 25K | $43.8K | $1.75 | May 19, 2021 | Direct |
Eledon Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 752K | May 1, 2023 | Direct | ||
RIGEL PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 30K | May 19, 2021 | Direct | ||
Emergent BioSolutions Inc. | Director | Stock Option (Right to Buy) | 25.7K | May 23, 2024 | Direct |